Based on the H&R GmbH & Co. KGaA stock forecast from 0 analysts, the average analyst target price for H&R GmbH & Co. KGaA is not available over the next 12 months. H&R GmbH & Co. KGaA’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of H&R GmbH & Co. KGaA is Neutral, which is based on 7 positive signals and 8 negative signals. At the last closing, H&R GmbH & Co. KGaA’s stock price was EUR 4.65. H&R GmbH & Co. KGaA’s stock price has changed by -2.72% over the past week, -6.06% over the past month and -24.02% over the last year.
No recent analyst target price found for H&R GmbH & Co. KGaA
No recent average analyst rating found for H&R GmbH & Co. KGaA
Company Overview H&R GmbH & Co. KGaA
H&R GmbH & Co. KGaA engages in the manufacture and sale of chemical-pharmaceutical raw materials and injection molded precision plastic parts. It operates in three segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment manufactures and distributes paraffins, white oils, plasticizers, base oils, lubricants, and other crude oil-based specialty products, as well as by-products, such as feedstocks and bunker fuels. The ChemPharm Sales segment processes and distributes plasticizers, wax emulsions, paraffins, and other crude oil-based specialty products. The Plastics segment develops, manufactures, and sells precision plastic parts, components, and medical consumables for medical technology, automotive, and other traditional industries. It provides emulsifiers and bases, waxes and emulsions, petroleum jellies, water-based waxes and oil-emulsions, motor and process oils, cable filling compounds. The company was formerly known as H&R Aktiengesellschaft and changed its name to H&R GmbH & Co. KGaA in August 2016. The company was founded in 1919 and is headquartered in Salzbergen, Germany Address: Neuenkirchener Strasse 8, Salzbergen, Germany, 48499 Read Less
H&R GmbH & Co. KGaA engages in the manufacture and sale of chemical-pharmaceutical raw materials and injection molded precision plastic parts. It operates in three segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment manufactures and distrib...Read More
Stock Target Advisor's fundamental analysis for H&R GmbH & Co. KGaA's stock is Neutral.
2HRA:XETRA stock's dividend yield is 2.15%.
Our analysis grades 2HRA:XETRA stock's dividend yield at D-. This means that 2HRA:XETRA stock's dividend yield is above 60% of the stocks in the Chemicals sector in the XETRA exchange.
Based on this 2HRA:XETRA may be a average dividend stock for its sector.
Unfortunately we do not have enough data on 2HRA:XETRA's stock to indicate what its average analyst target is.
2HRA:XETRA stock's Price/Earning ratio is 16.64.
Our analysis grades 2HRA:XETRA stock's Price / Earning ratio at A+. This means that 2HRA:XETRA stock's Price/Earning ratio is above 0% of the stocks in the Chemicals sector in the XETRA exchange.
Based on this 2HRA:XETRA may be undervalued for its sector.
The last closing price of 2HRA:XETRA's stock was EUR 4.65.
The most recent market capitalization for 2HRA:XETRA is EUR 0.17B.
Unfortunately we do not have enough analyst data on 2HRA:XETRA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains H&R GmbH & Co. KGaA's stock.
As per our most recent records H&R GmbH & Co. KGaA has 1,704 Employees.
H&R GmbH & Co. KGaA's registered address is Neuenkirchener Strasse 8, Salzbergen, Germany, 48499.
You can get more information about it from H&R GmbH & Co. KGaA's website at https://www.hur.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low debt
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
Underpriced on cashflow basis
The stock is trading low compared to its peers on a price to cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Underpriced on free cash flow basis
The stock is trading low compared to its peers on a price to free cash flow basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
What not to like
Poor capital utilization
The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.
Poor return on assets
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Poor return on equity
The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 2HRA:XETRA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
